News

LMCs defend primary care value

06-Jun-08

Darzi reforms and the value of GPs top the annual LMCs conference agenda reports Neil Durham.

LMC representatives from all over the UK will debate whether to call on the government to recognise how cheaply it is getting world-class primary care.

The motion forms part of the first debate at the two-day conference in London next week.

The news comes as London-wide LMCs issued a message backing GP's Valuing General Practice campaign. It said: 'Modern general practice is at the heart of family healthcare. Any campaign that highlights the threats to local GP services, which many patients and stakeholders might not be aware of, is worth supporting.'

The 2008 national LMCs conference in central London is called Standing Up For General Practice. Health minister Lord Ara Darzi features heavily in the agenda. The conference will debate whether the government should reconsider imposing a Darzi centre in each PCT, the concept of doctors other than accredited GPs performing primary medical services in Darzi clinics and a motion of no confidence in Darzi.

One motion calls for Choose and Book to be suspended with another suggesting it be renamed 'hide and seek' because it is not fit for purpose in its current format.

The GPC also faces criticism with one motion urging a no confidence vote in its ability to defend general practice. The motion states that the GPC has so far failed to convince the profession it has a credible strategy to counteract the government's wish to privatise the delivery of NHS primary care'.

GPC chairman Dr Laurence Buckman, who will make his first speech to the conference as chairman, told GP last week that he expected the more controversial motions, which include calls for mass undated resignations, to receive little support. 'I anticipate there will not be much support on the ground for resignations,' he said.

But the conference will not entirely be taken up recent changes. The perennial issue of changing patients returns. One motion reads: 'When procedures and services aren't commissioned locally and are therefore unavailable to patients as part of the NHS and patients request such procedures and services, GPs should be entitled to charge their NHS registered patients for clinically appropriate delivery of such procedures'.

Another motion suggests a test case for restriction of trade to 'allow GPs equity with their consultant colleagues'.

Other motions will call for publicity about the 'risks' of the shared records spine and whether a legal challenge should be made to the DDRB pay report.

neil.durham@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week